Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Active versus Passive Immunity01:31

Active versus Passive Immunity

12.0K
Immunity, along with the ability to limit pathogen growth to prevent significant body tissue damage, can be gained either by (1) actively developing an immune response within the individual after exposure to a pathogen or after getting vaccinated or (2) passively transferring immune components from an immune individual to one who is nonimmune. Both these forms of immunity can be found naturally and in medical practices.
Active Immunity
Active immunity refers to the resistance one develops...
12.0K
Vaccinations01:51

Vaccinations

53.7K
Overview
53.7K
Development of Immunocompetence01:22

Development of Immunocompetence

1.1K
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
1.1K
Vaccines01:21

Vaccines

42
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the...
42
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

3.1K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
3.1K
Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

1.8K
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
1.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Vital Signs: Trends and Disparities in Childhood Vaccination Coverage by Vaccines for Children Program Eligibility - National Immunization Survey-Child, United States, 2012-2022.

MMWR. Morbidity and mortality weekly report·2024
Same author

U.S. COVID-19 vaccine distribution strategies, systems, performance, and lessons learned, December 2020 - May 2023.

Vaccine·2024
Same author

CDC COVID-19 vaccination program: Healthcare provider compliance with COVID-19 vaccine requirements and recommendations.

Vaccine·2023
Same author

Disparities in COVID-19 Vaccination Coverage Among Health Care Personnel Working in Long-Term Care Facilities, by Job Category, National Healthcare Safety Network - United States, March 2021.

MMWR. Morbidity and mortality weekly report·2021
Same author

Provision of Pediatric Immunization Services During the COVID-19 Pandemic: an Assessment of Capacity Among Pediatric Immunization Providers Participating in the Vaccines for Children Program - United States, May 2020.

MMWR. Morbidity and mortality weekly report·2020
Same author

Implementation of the Standards for adult immunization practice: A survey of U.S. Health care providers.

Vaccine·2020
Same journal

Estimating clinical and economic impacts and cost-effectiveness of introducing 20-valent pneumococcal conjugate vaccine in Taiwan's pediatric National Immunization Program and impacts of a delayed implementation.

Human vaccines & immunotherapeutics·2026
Same journal

Safety and immunogenicity of a COVID-19-Influenza Combination nanoparticle vaccine (CIC) containing SARS-CoV-2 recombinant spike and quadrivalent influenza hemagglutinin with Matrix-M® adjuvant: A phase 1/2 clinical trial.

Human vaccines & immunotherapeutics·2026
Same journal

Randomized controlled trial evaluating immunogenicity and safety of a porcine circovirus-free rotavirus vaccine in healthy Chinese infants.

Human vaccines & immunotherapeutics·2026
Same journal

Determinants of HPV vaccination acceptance among young adult women in Japan's catch-up generation: A cross-sectional study.

Human vaccines & immunotherapeutics·2026
Same journal

Spatial accessibility analysis of vaccination units in Gansu Province, China (2025).

Human vaccines & immunotherapeutics·2026
Same journal

Pneumococcal vaccination awareness and uptake among high-risk patients attending internal medicine outpatient clinics: A cross-sectional study.

Human vaccines & immunotherapeutics·2026
See all related articles

Related Experiment Video

Updated: Mar 30, 2026

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens
13:47

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens

Published on: May 19, 2020

3.9K

U.S. Immunization program adult immunization activities and resources.

LaDora O Woods1, Carolyn B Bridges2, Samuel B Graitcer3

  • 1a Carter Consulting, Inc. , Atlanta , GA , USA.

Human Vaccines & Immunotherapeutics
|November 19, 2015
PubMed
Summary
This summary is machine-generated.

Adult immunization programs in the US show significant variation in resources and activities. Enhancing public health infrastructure and collaboration is crucial for improving adult vaccination coverage and preventing diseases.

Keywords:
adultimmunizationvaccines

More Related Videos

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
09:03

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on: June 19, 2018

9.4K
An Optimized Hemagglutination Inhibition HI Assay to Quantify Influenza-specific Antibody Titers
06:34

An Optimized Hemagglutination Inhibition HI Assay to Quantify Influenza-specific Antibody Titers

Published on: December 1, 2017

38.4K

Related Experiment Videos

Last Updated: Mar 30, 2026

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens
13:47

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens

Published on: May 19, 2020

3.9K
Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
09:03

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on: June 19, 2018

9.4K
An Optimized Hemagglutination Inhibition HI Assay to Quantify Influenza-specific Antibody Titers
06:34

An Optimized Hemagglutination Inhibition HI Assay to Quantify Influenza-specific Antibody Titers

Published on: December 1, 2017

38.4K

Area of Science:

  • Public Health
  • Immunization Programs
  • Health Policy

Background:

  • Adult immunization coverage in the US remains low, falling short of public health goals.
  • Vaccination recommendations for adults are based on age, health status, and lifestyle factors.
  • Effective adult immunization programs require dedicated resources and infrastructure.

Purpose of the Study:

  • To assess the resources and activities of state and local health department adult immunization programs in the US.
  • To identify variations in public health infrastructure supporting adult immunizations.
  • To inform strategies for improving adult vaccination rates.

Main Methods:

  • Analysis of 2012 and 2013 data from the Centers for Disease Control and Prevention's (CDC) Program Annual Reports and Progress Assessments (PAPA) survey.
  • Inclusion of responses from 56 of 64 CDC-funded US immunization programs.
  • Examination of data on adult immunization coordinators and coalitions.

Main Results:

  • A high percentage of programs reported having adult immunization coordinators, but many dedicated limited time to these activities.
  • A notable portion of programs incorporated adult immunization issues into broader coalitions rather than having separate adult-focused coalitions.
  • Significant variation exists across US public health departments in their infrastructure for supporting adult immunizations.

Conclusions:

  • Substantial disparities in public health infrastructure hinder adult immunization efforts nationwide.
  • Continued assessment of adult immunization programs is vital for improving coverage.
  • Collaborative efforts between health departments, providers, and partners are essential to increase adult vaccination rates and reduce vaccine-preventable diseases.